Company
Coultreon Biopharma
Transforming lives with groundbreaking treatments
- Status
- Operatingas of 2026-09-23Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Coultreon Biopharma's mission is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs.
Funding snapshot
- Total raised
- $125MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series A, $125M2026-04-28
Funding rounds
- Series A
- $125M2026-04-28, Company stated
Products
- Web
- COL-5671
- Other
- COL-5671 (SIK3)
Loading relationship preview